-
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
Hebon Group, 4 Sept 2021, In: Journal of the National Cancer Institute. 113, 9, p. 1203-1211 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
GEMO Study Collaborators, EMBRACE Collaborators, KConFab Investigators, HEBON Investigators & ABCTB Investigators, 1 Jan 2020, In: Nature genetics. 52, 1, p. 56-73 18 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Heemskerk-Gerritsen, B. A. M., Jager, A., Koppert, L. B., Obdeijn, A.I.-M., Collée, M., Meijers-Heijboer, H. E. J., Jenner, D. J., Oldenburg, H. S. A., van Engelen, K., de Vries, J., van Asperen, C. J., Devilee, P., Blok, M. J., Kets, C. M., Ausems, M. G. E. M., Seynaeve, C., Rookus, M. A. & Hooning, M. J., 1 Oct 2019, In: Breast Cancer Research and Treatment. 177, 3, p. 723-733 11 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
